NCT04090866View on ClinicalTrials.gov

Cardiac Metabolic Remodeling After Pulmonary Vasodilator Therapy in Pulmonary Arterial Hypertension: A Pilot Study

TerminatedOBSERVATIONAL
Enrollment

2

Participants

Timeline

Start Date

November 14, 2019

Primary Completion Date

July 21, 2020

Study Completion Date

July 21, 2020

Conditions
Pulmonary Arterial HypertensionRight-Sided Heart Failure
Interventions
OTHER

PET/MRI

Positron Emission Tomograph/Magnetic Resonance Imaging - participants will undergo PET/MRI prior to initiation of pulmonary vasodilator therapy and again 4-6 months after initiation of therapy

Trial Locations (1)

53792

University of Wisconsin-Madison, Madison

Sponsors

Collaborators (1)

United Therapeutics
All Listed Sponsors
collaborator

United Therapeutics

INDUSTRY

lead

University of Wisconsin, Madison

OTHER